Broker's call: Divis Laboratories
Anand RathiDivis Laboratories (Buy)Target: 4,095CMP: 3688.90Divis Laboratories is one of the leading manufacturers of Active Pharmaceutical Ingredie09-12-2020
09-12-2020
Buy Divis Laboratories: target of Rs 4175: Sharekhan
Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 4175 in its research report dated December 04, 2020.07-12-2020
DIVI'S LABORATORIES LTD. - 532488 - Commencement Of Construction Of Divi''s Laboratories Unit-III Facility Near Kakinada
We hereby announce the commencement of construction of Divi''s Laboratories Unit-III Facility (the Project) at Kona Forest, Ontimamidi Village, Thondangi Mandal, Near Kakinada, East Godavari District, Andhra Pradesh from the 7th December, 2020. The Company will be investing about Rs. 1500 crores out of its internal accruals in phased manner for the implementation of its Unit III facility. The operations are likely to commence within 12 to 18 months for 1st phase of the Project. All the requisite licenses have been granted by the Government of India and Government of Andhra Pradesh for implementation of the Project. This is for your information and records.01-12-2020
DIVI'S LABORATORIES LTD. - 532488 - Submission Of Half Yearly Disclosure On Related Party Transactions- 30.09.2020
Pursuant to Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015, we enclose disclosure of Related Party Transactions on a consolidated basis, in the format specified in the accounting standards, for the half year ended 30 September, 2020. This is for your information and records.23-11-2020
DIVI'S LABORATORIES LTD. - 532488 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Information regarding loss of share certificate17-11-2020
Top stock picks by Nilesh Jain of Anand Rathi: Buy Coforge, Divis Labs
The momentum indicator RSI has also breached the falling trend line and MACD provided a fresh buy crossover on the daily chart which hints of further positive momentum in Divis Labs13-11-2020
Buy Divis Laboratories: target of Rs 3800: Sharekhan
Sharekhan is bullish on Divis Laboratories recommended buy rating on the stock with a target price of Rs 3800 in its research report dated November 06, 2020.11-11-2020
Divis Labs share price hits 52-week high after Q2 profit jumps 45%
The drug firm reported a 45.63 percent rise in its consolidated net profit at Rs 519.59 crore for the quarter ended September 30, mainly on account of robust sales.09-11-2020
Earnings Call for Q2FY21 of Divi's Laboratories Ltd.
Conference Call with Divi's Laboratories Management and Analysts on Q2FY21 Performance and Outlook. Listen to the full earnings transcript.07-11-2020
DIVI'S LABORATORIES LTD. - 532488 - Outcome Of Board Meeting Held On 07 November, 2020
As enclosed.07-11-2020